OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries
Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Javier Gállego, et al.
Cancer Investigation (2021) Vol. 40, Iss. 1, pp. 1-13
Closed Access | Times Cited: 12
Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Javier Gállego, et al.
Cancer Investigation (2021) Vol. 40, Iss. 1, pp. 1-13
Closed Access | Times Cited: 12
Showing 12 citing articles:
Obesity and renal cell carcinoma: Biological mechanisms and perspectives
Neha Venkatesh, Alberto Martini, Jennifer L. McQuade, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 21-33
Open Access | Times Cited: 18
Neha Venkatesh, Alberto Martini, Jennifer L. McQuade, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 21-33
Open Access | Times Cited: 18
The Big Data Paradox in Clinical Practice
Pavlos Msaouel
Cancer Investigation (2022) Vol. 40, Iss. 7, pp. 567-576
Open Access | Times Cited: 26
Pavlos Msaouel
Cancer Investigation (2022) Vol. 40, Iss. 7, pp. 567-576
Open Access | Times Cited: 26
Interpreting Randomized Controlled Trials
Pavlos Msaouel, Juhee Lee, Peter F. Thall
Cancers (2023) Vol. 15, Iss. 19, pp. 4674-4674
Open Access | Times Cited: 15
Pavlos Msaouel, Juhee Lee, Peter F. Thall
Cancers (2023) Vol. 15, Iss. 19, pp. 4674-4674
Open Access | Times Cited: 15
A Causal Framework for Making Individualized Treatment Decisions in Oncology
Pavlos Msaouel, Juhee Lee, José A. Karam, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3923-3923
Open Access | Times Cited: 22
Pavlos Msaouel, Juhee Lee, José A. Karam, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3923-3923
Open Access | Times Cited: 22
Perception, Cognition and Thought: Part I Nature, Evolution and Development of Conceptual and Symbolic Processes
Gary H. Lyman
Cancer Investigation (2023) Vol. 41, Iss. 6, pp. 535-538
Open Access | Times Cited: 10
Gary H. Lyman
Cancer Investigation (2023) Vol. 41, Iss. 6, pp. 535-538
Open Access | Times Cited: 10
Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive
Andrew W. Hahn, Nazlı Dizman, Pavlos Msaouel
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 13
Andrew W. Hahn, Nazlı Dizman, Pavlos Msaouel
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 13
Risk Model Development and Validation in Clinical Oncology: Lessons Learned
Gary H. Lyman, Pavlos Msaouel, Nicole M. Kuderer
Cancer Investigation (2022) Vol. 41, Iss. 1, pp. 1-11
Closed Access | Times Cited: 7
Gary H. Lyman, Pavlos Msaouel, Nicole M. Kuderer
Cancer Investigation (2022) Vol. 41, Iss. 1, pp. 1-11
Closed Access | Times Cited: 7
Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit
Vicente Valentí, Paula Jiménez‐Fonseca, Pavlos Msaouel, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 184-188
Open Access | Times Cited: 6
Vicente Valentí, Paula Jiménez‐Fonseca, Pavlos Msaouel, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 184-188
Open Access | Times Cited: 6
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Paula Jiménez‐Fonseca, Victoria Foy, Sophie Raby, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 2
Paula Jiménez‐Fonseca, Victoria Foy, Sophie Raby, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 2
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
Javier Gállego, Aránzazu Arias‐Martínez, Arturo Lecumberri, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100514-100514
Open Access | Times Cited: 4
Javier Gállego, Aránzazu Arias‐Martínez, Arturo Lecumberri, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100514-100514
Open Access | Times Cited: 4
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
Sena Valcárcel González, Javier Gállego, Paula Jiménez‐Fonseca, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 4077-4089
Closed Access | Times Cited: 3
Sena Valcárcel González, Javier Gállego, Paula Jiménez‐Fonseca, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 4077-4089
Closed Access | Times Cited: 3
Interpreting Randomized Controlled Trials
Pavlos Msaouel, Juhee Lee, Peter F. Thall
(2023)
Open Access | Times Cited: 1
Pavlos Msaouel, Juhee Lee, Peter F. Thall
(2023)
Open Access | Times Cited: 1
